W-S Huang1, C-H Tseng1, C-L Lin2, C-H Tsai1, C-H Kao3. 1. From the Department of Neurology, China Medical University Hospital, Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, Management Office for Health Data, China Medical University Hospital and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan From the Department of Neurology, China Medical University Hospital, Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, Management Office for Health Data, China Medical University Hospital and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan. 2. From the Department of Neurology, China Medical University Hospital, Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, Management Office for Health Data, China Medical University Hospital and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan. 3. From the Department of Neurology, China Medical University Hospital, Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, Management Office for Health Data, China Medical University Hospital and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan From the Department of Neurology, China Medical University Hospital, Graduate Institute of Clinical Medical Science and School of Medicine, College of Medicine, Management Office for Health Data, China Medical University Hospital and Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan d10040@mail.cmuh.org.tw.
Abstract
BACKGROUND AND PURPOSE: The association of Helicobacter pylori infection (HP-I) with ischemic stroke (IS) incidence has been studied, but conflicting results have been reported. The purpose of this study was to investigate the association between chronic HP-I and the risk of acute IS by using data from the Taiwan National Health Insurance Research Database. METHODS: We identified17 332 patients with HP-I and 69 328 randomly selected age- and gender-matched controls from 1 January 2000 to 31 December 2010. Both cohorts were followed up until the occurrence of IS or until censored. The Cox proportional hazards model was used for assessing the association of HP-I with IS. RESULTS: Compared with the control cohort, patients diagnosed with HP-I exhibited a higher incidence rate of IS (14.8 vs. 8.45 per 1000 person years) and a hazard ratio (HR) of 1.52 (95% confidence interval [CI] = 1.40-1.65). The HRs for IS were 1.49 (1.37-1.62) in patients diagnosed with HP-I who had one admission, increasing to 2.26 (1.71-1.98) for those who had two or more admissions when adjusted for age, sex and comorbidities (P for trend < 0.0001). In addition, we observed a significantly positive association between nonembolic IS and increased admissions (P for trend < 0.0001) but negative association with embolic IS. CONCLUSION: Chronic HP-I is significantly associated with an increased risk of IS, particularly nonembolic IS. Anti-HP therapy may be beneficial to IS prevention.
BACKGROUND AND PURPOSE: The association of Helicobacter pylori infection (HP-I) with ischemic stroke (IS) incidence has been studied, but conflicting results have been reported. The purpose of this study was to investigate the association between chronic HP-I and the risk of acute IS by using data from the Taiwan National Health Insurance Research Database. METHODS: We identified17 332 patients with HP-I and 69 328 randomly selected age- and gender-matched controls from 1 January 2000 to 31 December 2010. Both cohorts were followed up until the occurrence of IS or until censored. The Cox proportional hazards model was used for assessing the association of HP-I with IS. RESULTS: Compared with the control cohort, patients diagnosed with HP-I exhibited a higher incidence rate of IS (14.8 vs. 8.45 per 1000 person years) and a hazard ratio (HR) of 1.52 (95% confidence interval [CI] = 1.40-1.65). The HRs for IS were 1.49 (1.37-1.62) in patients diagnosed with HP-I who had one admission, increasing to 2.26 (1.71-1.98) for those who had two or more admissions when adjusted for age, sex and comorbidities (P for trend < 0.0001). In addition, we observed a significantly positive association between nonembolic IS and increased admissions (P for trend < 0.0001) but negative association with embolic IS. CONCLUSION: Chronic HP-I is significantly associated with an increased risk of IS, particularly nonembolic IS. Anti-HP therapy may be beneficial to IS prevention.
Authors: Soo Hyun Jang; Hyejin Lee; Jun Suk Kim; Hyun Jung Park; Su Min Jeong; Sang-Hyun Lee; Hyun Ho Kim; Jin Ho Park; Dong Wook Shin; Jae Moon Yun; BeLong Cho; Hyung-Min Kwon Journal: Korean J Fam Med Date: 2015-09-18